Bio-Rad Laboratories | BIO - Market Capitalization


Bio-Rad Laboratories reported $6.22B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Agilent USD 41.49B 8.93B Sep/2025
Becton, Dickinson and Co. USD 51.01B 4.28B Feb/2026
Bio Techne USD 10.78B 1.62B Feb/2026
Bio-Rad Laboratories USD 6.7B 908M Feb/2026
Bruker USD 5.69B 1.47B Feb/2026
Charles River Laboratories USD 8.08B 1.94B Feb/2026
Danaher USD 161.7B 29.34B Dec/2025
Exact Sciences USD 10.36B 334M Sep/2025
General Electric Aerospace USD 324.91B 5.91B Dec/2025
Hologic USD 16.62B 1.67B Dec/2025
Illumina USD 21.21B 588M Feb/2026
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Laboratory Of America USD 23.77B 2.98B Feb/2026
Merck USD 300.37B 39.11B Feb/2026
Mettler Toledo International USD 29.7B 1.22B Feb/2026
Myriad Genetics USD 494M 316M Jun/2025
OraSure Technologies USD 435M 68M Sep/2023
Pacific Biosciences Of California USD 2.62B 532M Dec/2023
Quest Diagnostics USD 23.09B 3.79B Feb/2026
Repligen USD 7.52B 532M Sep/2025
Revvity USD 12.58B 1.61B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Siemens EUR 196.26B 4.94B Feb/2026
Standard Biotools USD 521M 24M Feb/2026
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Tosoh JPY 828.29B 63.7B Feb/2026
Waters USD 19.14B 3.47B Feb/2026